papillary RCC

Related by string. * Papillary : papillary renal cell carcinoma . papillary thyroid cancer . papillary thyroid carcinoma . papillary carcinoma . papillary carcinoma form . papillary muscle . papillary tumors . muscle invasive papillary / RCCS . RCCs : Renal Cell Carcinoma RCC . RCC IWS . NYSE RSO RCC . created checks RCCs . metastatic RCC . RCC dec . RCC Consultants . cell carcinoma RCC * *

Related by context. All words. (Click for frequent words.) 69 TIMP 1 67 TIMP 67 colorectal carcinoma 67 sarcomatoid 67 metaplasia 67 P2X 67 GSTP1 66 mRNA expression 66 K ras mutations 66 peritoneal carcinomatosis 66 ERBB2 66 papillary renal cell carcinoma 66 constitutively active 66 downregulated 66 pulmonary metastases 66 epithelial tumors 66 transgene expression 66 cell adhesion molecule 66 5alpha reductase 66 pancreatic adenocarcinoma 66 urothelial carcinoma 66 IFN α 65 ligand receptor 65 carcinoembryonic antigen 65 intercellular adhesion molecule 65 hepatoma 65 VEGFR1 65 succinate dehydrogenase 65 MAPK pathway 65 TET2 65 monocyte chemotactic protein 65 neoplastic 65 breast carcinomas 65 haematopoietic 65 PIK3CA 65 CD# CD# 65 hepatocellular carcinomas 65 metachronous 65 calcium calmodulin dependent 65 C#Y 65 ERK1 2 65 P selectin 65 isoenzyme 65 RAS RAF MEK 65 Immunohistochemical analysis 65 colorectal adenoma 65 methylenetetrahydrofolate reductase 65 IGFBP 65 cisplatin resistant 65 FGFR1 65 MEK1 64 androgen receptor AR 64 hamartomas 64 coexpression 64 mucinous 64 cyclin E 64 liver metastasis 64 morphogen 64 urothelial 64 Supplementary Table 64 TRAIL R1 64 transmembrane protein 64 HDACi 64 Fas ligand 64 thyroglobulin 64 FGFR2 64 glomerular 64 IL #p# 64 polycystin 64 LRAT 64 prostate carcinoma 64 proto oncogene 64 potent inhibition 64 immunostaining 64 activin 64 5 hydroxytryptamine 64 IGF1R 64 Angiotensin converting enzyme 64 Clusterin 64 histologic subtype 64 EGF receptor 64 immunohistochemical 64 Gleevec resistant 64 serine protease 64 VEGF receptor 64 breast cancer subtypes 64 mutated p# 64 pro angiogenic 64 COL#A# 64 phosphatidylinositol 63 LRP5 63 Janus kinase 63 pDCs 63 erythroid 63 apolipoproteins 63 Histologic 63 Leydig cell 63 mediated inhibition 63 acinar 63 beta subunit 63 CD1d 63 IFN ß 63 adenocarcinomas 63 induces apoptosis 63 site directed mutagenesis 63 activating mutation 63 cystatin 63 M1 muscarinic 63 apo AI 63 adipogenic 63 imatinib resistant 63 lymphocytosis 63 protein tyrosine phosphatase 63 hypoxia inducible factor 63 serine threonine 63 ovarian carcinoma 63 ventricular myocardium 63 daunorubicin 63 caveolin 1 63 HepG2 cells 63 p# mitogen activated 63 antiproliferative effects 63 integrin alpha 63 homodimers 63 colon carcinoma 63 missense mutations 63 lymph node metastasis 63 Rab5 63 RRM1 63 syngeneic 63 FLT3 63 vesicle fusion 63 TCF#L# 63 pDC 63 tumorigenicity 63 papillary 63 Hypoxia Inducible Factor 63 KRAS mutant 63 condensin 63 astrocytomas 63 homozygotes 63 somatostatin 63 transcriptional regulators 63 Protein Kinase C 63 Flt3 63 BRAF V#E 63 constitutively expressed 63 Circulating tumor cells 63 CXCL# 63 KRAS oncogene 63 gastric carcinoma 63 ependymomas 63 FGFR3 63 COX2 63 Fibroblast Growth Factor Receptor 63 renal cell carcinomas 63 CC genotype 63 mononuclear 63 uPAR 63 E selectin 63 substrate specificity 63 antisense inhibition 63 IL 1ß 63 N Myc 63 osteoclast 63 cytokeratin 63 SSc 63 cotransporter 62 phosphoprotein 62 HIF 1alpha 62 β1 62 invasive ductal 62 dinucleotide 62 monocyte chemoattractant protein 62 Tie2 62 transferase 62 PDGF receptor 62 renal tumors 62 c MET 62 CCL# 62 μg ml 62 FDG uptake 62 contralateral breast 62 endometrioid 62 beta tubulin 62 lymph node metastases 62 TNFa 62 thymic 62 PDGFR 62 nonmetastatic 62 CYT# potent vascular disrupting 62 c MYC 62 aggrecan 62 Upregulation 62 MTHFR gene 62 lymphangiogenesis 62 Figure 2C 62 T#I [002] 62 lipoxygenase 62 vimentin 62 regulated kinase 62 Cyclin E 62 thymosin 62 CagA 62 microsatellite instability 62 liposomal formulation 62 5HT 62 nonsmall cell lung cancer 62 colorectal adenocarcinoma 62 MAP kinase 62 C#T [002] 62 TP# gene 62 methyltransferase 62 protein tyrosine kinase 62 ERK signaling 62 PTHrP 62 tyrosine phosphorylation 62 HGPIN 62 CHD5 62 TGFß 62 NFkB 62 proximal tubule 62 neuroendocrine carcinoma 62 HbF 62 fibrillar 62 selective inhibition 62 germinal center 62 interferon IFN 62 BMP2 62 deoxy 62 mutated K ras 62 secretory pathway 62 BRAF V#E mutation 62 breast carcinoma 62 serous ovarian cancer 62 hematopoietic progenitors 62 clonogenic 62 LNCaP cells 62 cytidine 62 1 diabetes T1D 62 cyclic AMP cAMP 62 murine model 62 Eg5 62 μmol L 62 histologies 62 transduced 62 idarubicin 62 transgenic mouse models 62 IFN alpha 62 biliary tract cancer 62 claudin 62 Raf MEK ERK 62 MMP# 62 glycogen synthase kinase 62 pyrimidines 62 miRNA expression 62 hypothalamic pituitary 62 GNAQ 62 Nedd4 62 PI3K Akt 62 TGF alpha 62 NKG2D 62 ApoE 62 basal cell carcinoma BCC 62 chemo immunotherapy 62 CDK4 62 Rap1 62 hTERT 62 dasatinib Sprycel 62 synuclein 62 xenograft models 62 costimulatory molecules 62 PC# cells 62 MSH2 62 deacetylation 62 cathepsin B 62 gastric adenocarcinoma 62 interleukin IL 62 KIF6 gene 62 #HT#A 62 glycosyltransferase 62 lymphoid cells 62 adenylyl cyclase 62 Vps# 62 cells transfected 62 glycosylated 62 monocytes macrophages 62 γ secretase 62 Dysregulation 62 inducible nitric oxide synthase 62 cardiac fibroblasts 62 MLH1 62 microglial activation 62 p# MAPK 62 promoter methylation 62 polyamine 62 MGd 62 isoenzymes 62 NOD mouse 62 esophageal squamous cell carcinoma 62 Secretase 62 metalloproteinase 62 HER2 receptor 62 photosystem II 62 dipeptide 62 overexpress 62 IL 1β 61 T1a 61 tetramer 61 cyclooxygenase COX 61 ERK pathway 61 stage IIIA 61 lung carcinomas 61 TNF α 61 adhesion molecule 61 splice variants 61 PTPN# 61 mediated apoptosis 61 alkylating 61 ABCB1 61 MLL2 61 cyclin dependent kinase inhibitor 61 proteomic analysis 61 BMP signaling 61 tumoral 61 PTEN protein 61 somatostatin receptor 61 Tubulin 61 adrenoceptor 61 sodium glucose cotransporter 61 matrix metalloproteinase 61 cellularity 61 radiosensitivity 61 Th1 61 cellular prion protein 61 RASSF1A 61 apoA 61 Purkinje cell 61 MTHFR 61 hydroxylase 61 HIF 1a 61 pleomorphic 61 KRAS wild 61 IL #R 61 cAMP signaling 61 synaptotagmin 61 vWF 61 matrix metalloproteinases 61 constitutively activated 61 defensin 61 bcl 2 61 pyrimidine 61 IL 1beta 61 interferon γ 61 Notch signaling pathway 61 amyloid deposition 61 myc 61 miR #a [001] 61 tumor xenograft models 61 unmutated 61 methionine aminopeptidase 61 IDH1 mutation 61 PSADT 61 hypermethylation 61 collagen degradation 61 p#NTR 61 tNOX 61 SMN1 61 FGFR4 61 FKBP# 61 intact parathyroid hormone 61 c Myb 61 radiolabeled antibodies 61 stage IIIB 61 thyrotropin 61 retinoic acid receptor 61 Fig. 1D 61 immunohistochemical staining 61 xenograft tumors 61 carcinoid 61 extracellular domain 61 glutamyl 61 RANTES 61 gene polymorphism 61 TMEM#B 61 GRASPA ® 61 TMPRSS2 ERG fusion 61 paricalcitol 61 NF1 gene 61 inhibitory receptor 61 1beta 61 costimulation 61 fibrin deposition 61 penetrance 61 agonism 61 cytokine IL 61 caveolin 61 rs# [002] 61 galectin 61 GISTs 61 B7 H3 61 glucose transporter 61 HLA G 61 PIP2 61 lesional 61 colorectal liver metastases 61 apolipoprotein 61 astrocytic 61 beta1 integrin 61 PML RARA 61 micrometastases 61 Foxp3 61 wildtype 61 carcinoids 61 nutlin 3a 61 Stromal 61 SH2 domain 61 PU.1 61 castration resistant 61 gemcitabine Gemzar ® 61 histologic 61 laminin 61 clinicopathological 61 cytokine signaling 61 NFκB 61 TNFalpha 61 receptor inhibitor 61 LKB1 61 leukocyte adhesion 61 ,#,# [002] 61 PCa 61 glutamic acid decarboxylase 61 pheochromocytoma 61 grade cervical intraepithelial 61 constitutively 61 multicentric 61 BCR ABL mutations 61 hypomethylation 61 TRAIL R2 61 pretargeting 61 hematopoietic 61 TMPRSS2 ERG 61 MT1 MMP 61 transcriptional regulation 61 vascular endothelial 61 hyperplastic 61 thymidine 61 squamous cell carcinoma SCC 61 ß catenin 61 integrin expression 61 EGFR HER2 61 peptide receptor 61 epithelia 61 chromosomal aberrations 61 leiomyoma 61 S#A# [002] 61 endonuclease 61 hepato 61 PC3 cells 61 alveolar epithelial cells 61 intraepithelial 61 dimerization 61 epithelial ovarian 61 TGF ß1 61 CCR5 delta# 61 heterozygotes 61 CD8 + 61 androgen independent 61 RAR beta 61 mitogen activated protein kinase 61 annexin 61 IGFBP 3 61 acyl CoA 61 erlotinib Tarceva ® 61 Macrophage 61 abnormal p# 61 V#F mutation 61 poly ADP ribose polymerase 61 61 malignant prostate 61 Haptoglobin 61 urothelial cancer 61 prostaglandin E 61 myelofibrosis polycythemia vera 61 ERCC1 61 lung metastases 61 colorectal carcinomas 61 Supplementary Fig 61 IGF IR 61 ^ sup #m 61 Interferon gamma 60 Mutational 60 ERalpha 60 PPARγ 60 pT2 60 pulmonary metastasis 60 EGFRvIII 60 NMIBC 60 leukemia AML 60 pegylated liposomal doxorubicin 60 E cadherin expression 60 prognostic biomarker 60 costimulatory 60 ERa 60 H#K#me# 60 Akt1 60 transfected cells 60 plasmacytoid 60 melatonin receptor 60 ribosomal protein 60 urocortin 60 neurofibromatosis type 60 interleukin IL -6 60 DHFR 60 TNFR 60 parenchyma 60 p# p# 60 thyroid hormone receptor 60 antiangiogenic 60 TRAIL induced apoptosis 60 premalignant 60 KLF# 60 FUS1 60 serum TSH 60 neoplasm 60 TOP2A 60 chemokine receptor 60 BCR ABL1 60 metastatic lymph nodes 60 ribonuclease 60 #p# [003] 60 NOD SCID mice 60 Sgk1 60 β catenin 60 lactate dehydrogenase LDH 60 osteoblast 60 Galectin 60 androgen dependent 60 cortisol receptor 60 chemoresistance 60 ADPKD 60 unmethylated 60 prognostic indicator 60 complement inhibitor eculizumab 60 clade B 60 E#F# 60 thymocyte 60 myeloproliferative diseases 60 lactate dehydrogenase 60 N glycan 60 lymphoid 60 beta globin 60 B Raf 60 null mice 60 Xanafide 60 CD# expression [002] 60 microglial 60 Neuregulin 1 60 miR #b [001] 60 DEAR1 60 KLF4 60 thyroid carcinomas 60 quinone 60 epithelioid 60 bispecific 60 unresectable tumors 60 TP# mutations 60 glycolytic 60 neuropilin 60 EGFR receptor 60 phosphoinositide 60 liver metastases 60 intracellular signaling 60 5 lipoxygenase 60 prostate cancer PCa 60 DNA intercalator 60 tumor suppressive 60 lobular carcinoma 60 HCV genotypes 60 HER2 HER2 60 endostatin 60 miRNAs miR 60 alkaline phosphatase 60 mRNA encoding 60 novel VDA molecule 60 GIST tumors 60 IL #E 60 lysophosphatidic acid 60 relapsed MM 60 pancreatic endocrine 60 nonalcoholic steatohepatitis NASH 60 immunoreactivity 60 Aromatase 60 kidney allograft 60 p# mutations 60 alpha synuclein protein 60 histologic subtypes 60 selective agonist 60 catenin 60 experimental autoimmune encephalomyelitis 60 paralogs 60 chemosensitivity 60 CEACAM1 60 intratumoral 60 miR #a [002] 60 RecA 60 metastatic colorectal 60 independent prognostic marker 60 dimeric 60 HLA DR 60 receptor kinase 60 xenograft model 60 MTT assay 60 macroalbuminuria 60 STAT4 60 granzyme B 60 Ala Ala 60 antiproliferative activity 60 myeloid 60 thrombin receptor 60 Sezary syndrome 60 radical nephrectomy 60 gastrointestinal stromal tumors 60 metastatic lesions 60 WT1 60 Dpp 60 transgenic rats 60 locoregional recurrence 60 melanocyte 60 HuR 60 proline rich 60 liposomal doxorubicin 60 antigenic epitopes 60 antisense oligonucleotide 60 MLL gene 60 CTLs 60 budding yeast 60 kidney urologic 60 demonstrated antitumor activity 60 alpha2 60 HNSCC 60 RNA polymerases 60 effector function 60 procollagen 60 colocalization 60 lytic 60 PKC inhibitor 60 orally administered inhibitor 60 hypermethylated 60 cytokine receptor 60 ADAMTS# 60 metastases 60 PI3K AKT 60 chromosomal mutations 60 serine threonine kinase 60 Fibroblast 60 CCR7 60 familial amyloidotic polyneuropathy FAP 60 Estrogen Receptor 60 rhIGFBP 3 60 TOP2A gene 60 KLF2 60 ectopic expression 60 phagocytosis 60 alternatively spliced 60 HT 2A 60 C. albicans 60 heterodimers 60 Amino acid 60 BMAL1 60 lipid accumulation 60 ultrastructure 60 Gly 60 proteoglycan 60 60 cyclin dependent kinase 60 carboxyl terminal 60 schwannomas 60 Smad3 60 potently inhibited 60 normal karyotype 60 localized renal 60 GPI anchored 60 HBeAg negative 60 ALB # 60 benign neoplasms 60 ANCA associated 60 antitumor effect 60 peripheral blood mononuclear 60 ductal adenocarcinoma 60 essential thrombocythemia 60 gastrointestinal stromal tumors GISTs 60 eotaxin 60 apoE 60 Epidermal Growth Factor Receptor 60 systemic anaplastic large 60 monocytic 60 APOL1 60 histopathologic examination 60 nonischemic 60 interferon alfa 60 adipokine 60 fallopian tube cancers 60 CBLC# 60 GlcNAc 60 motor neuron degeneration 60 EGFr 60 anti CD3 60 uM 60 fig. S2 60 peritumoral 60 myeloproliferative 60 Six3 60 Supplemental Figure 60 transfected 60 thyroid carcinoma 60 germline mutations 60 HepG2 60 protein tyrosine phosphatase 1B 60 Phosphorylation 60 JNK1 60 nitric oxide synthase NOS 60 mesangial 60 ccRCC 60 Peroxisome proliferator activated 60 perilipin 60 t# c# CLA 60 mosaicism 60 cell carcinomas 60 autoantibody 60 Figure 1A 60 MMP2 60 plasminogen activator inhibitor 60 esophageal carcinoma 60 fibrotic disease 60 gastric mucosa 60 Vidofludimus 60 BRAF mutations 60 beta3 60 postoperative chemotherapy 60 K RAS 60 regulated kinase ERK 60 isoprostane 60 porphyrin 60 sequence homology 60 Akt activation 60 hematopoietic cells 60 ganglioside 60 epididymal 60 oncogenic transformation 60 fig. S1 60 CD# expression [001] 60 advanced adenoma 60 MDM2 60 hENT1 60 TGF β 60 bone morphogenic protein 60 tumor metastases 60 amino terminal 60 metabolomic profiles 60 F FLT 60 tropomyosin 60 MALT lymphoma 60 selectively binds 60 Integrin 59 LRP6 59 Papillary 59 59 hormone receptor negative 59 C1q 59 FGFs 59 p# activation 59 atypical hyperplasia 59 fibulin 59 microcephalin 59 alanine aminotransferase ALT 59 antiapoptotic 59 neoplasia CIN 59 LPA1 receptor 59 baseline LDH 59 MMP9 59 CaM 59 homolog 59 operable breast cancer 59 amyloidogenic 59 homodimer 59 peptide antigens 59 BRCA deficient 59 Leydig cells 59 apolipoprotein B 59 TrkA 59 BCL2 59 differentiated thyroid 59 1alpha 59 DNA methylation patterns 59 CDH1 59 ABL1 59 JAK2 enzyme 59 Lymphocytic 59 prostate cancer CaP 59 transiently transfected 59 Polymerase 59 eIF2 59 MDR1 59 untranslated regions 59 muscarinic receptors 59 Nf1 59 ependymoma 59 diphosphate 59 evolutionarily conserved 59 CTAP# Capsules 59 isoform 59 apoptotic pathway 59 IL6 59 HER2 overexpression 59 HER2/neu 59 extranodal 59 anaphase promoting complex 59 topoisomerase 59 cytolytic 59 bladder carcinoma 59 IFN gamma 59 #T# L1 59 unresectable stage 59 pT3 59 osteogenic 59 gene inactivation 59 thrombospondin 59 TGFBR1 59 synthases 59 tumor antigen 59 autophagic 59 Wnt beta catenin 59 neuronal differentiation 59 hepatic metastases 59 Histologically 59 ELISPOT assay 59 neurite outgrowth 59 lymphoid organs 59 Vpu 59 receptor tyrosine kinase 59 steroidogenesis 59 neovascularization 59 malignant pancreatic 59 Epstein Barr Virus EBV 59 nucleolin 59 SLC#A# [002] 59 FISH fluorescence 59 completely resected 59 RIP1 59 follicular lymphomas 59 K ras gene 59 epithelial cells lining 59 IFNs 59 trophoblasts 59 kinase pathway 59 depsipeptide 59 α β 59 Nucleic acids 59 histone deacetylases 59 #S rRNA 59 59 anaplastic 59 JAK1 59 p# biomarker 59 β amyloid 59 neuroblastoma tumors 59 methylation patterns 59 Heterozygous 59 transgenic mouse model 59 Radical prostatectomy 59 advanced adenomas 59 leukemic stem cells 59 diabetes mellitus DM 59 K#N 59 GSTM1 59 orthotopic 59 azacytidine 59 concurrent chemoradiation 59 malignant phenotype 59 Huntingtin 59 IGFBP2 59 orthotopic model 59 ATG#L# 59 lyase 59 factor HGF 59 osteoblastic 59 vascular endothelial cells 59 aspartyl 59 Fig. 2A 59 mimetic peptide 59 vacuolar 59 cystic fibrosis transmembrane conductance 59 bronchial epithelial cells 59 GPC3 59 Pim kinases 59 metaphase 59 ouabain 59 CXCR4 expression 59 SOD1 59 Catenin 59 PTEN gene 59 bFGF 59 HSF1 59 haematologic 59 amacrine 59 hematopoietic progenitor cells 59 reductase 59 EphA2 59 locoregional 59 coactivator 59 receptor alpha 59 2 microglobulin 59 NS5A 59 papillomas 59 IFN γ 59 papillary thyroid carcinoma 59 CTGF 59 micrometastasis 59 immunoregulatory 59 HMGA2 59 cytokine interleukin 59 Nilotinib 59 hepatocellular cancer 59 overexpression 59 alkylating agent 59 chromosome #p#.# 59 CD#b 59 idiopathic myelofibrosis 59 IL 1Ra 59 scintigraphic 59 YONDELIS R 59 small molecule activators 59 superoxide dismutase 59 ultrastructural 59 oligomeric 59 Glioma 59 IRS1 59 dose dependently 59 cell adhesion molecules 59 aberrant activation 59 VEGF expression 59 endoplasmic reticulum stress 59 Selective Inhibitor 59 leukemic cell 59 mineralocorticoid receptor 59 ALK mutations 59 caspase activation 59 p tau 59 sorafenib Nexavar ® 59 glucokinase 59 cytoreductive nephrectomy 59 splenocytes 59 mTOR signaling 59 DR4 59 amyloid β 59 preoperative chemotherapy 59 DLC1 59 mutational status 59 FGF signaling 59 HLA B# 59 pertussis toxin 59 granulocyte 59 kinase inhibition 59 homologs 59 gene rearrangements 59 Cdc7 59 non coding RNA 59 Kinesin 59 medically inoperable 59 immunoreactive 59 medulloblastomas 59 Annexin V 59 muscle actin 59 somatostatin analog 59 ACh 59 cystatin C 59 β2 59 Th1 cells 59 BCG refractory 59 imatinib Gleevec 59 cyclin dependent kinases CDKs 59 RAF kinase 59 paragangliomas 59 downregulation 59 beta1 59 Tumour Necrosis Factor 59 LHRH receptor positive 59 CLL cells 59 S1P 59 lymphovascular invasion 59 underlying vasculopathy 59 neurotrophin 59 tumor suppressor protein 59 collagens 59 alkaline phosphatase ALP 59 neuroligins 59 transaminases 59 murine models

Back to home page